Monographie - Pentamidine isetionate

Последно актуализиране :
08/05/2024

Pentamidine isetionate

Химична структура

Търговско наименование

Търговските имена са примерни и съставът на помощните вещества може да бъде различен в зависимост от държавата и лабораториите

DBL Pentamidine isetionate	Малайзия
Manicare	Аржентина
Nebupent	Съединени Американски щати / САЩ
Pentacarinat	Австрия, Белгия, Великобритания, Германия, Гърция, Дания, Испания, Италия, Колумбия, Люксенбург, нова Зеландия, Финландия, Франция, Холандия, Швейцария, Швеция
Pentam	Съединени Американски щати / САЩ
Pentamidina	Аржентина, Испания
Pentamidine isethionate	Австралия, Канада, Малайзия, Съединени Американски щати / САЩ
Pentamina	Португалия

Библиография : Pentamidine isetionate

	Вид	Публикация
36	Списание	Alex S, Gupta SL, Minor JR, Turcovski-Corrales S, Gallelli JF, Taub D, Piscitelli SC. Compatibility and activity of aldesleukin (recombinant interleukin-2) in presence of selected drugs during simulated Y-site administration: Evaluation of three methods. Am J Health-Syst Pharm 1995 ; 52: 2423-2426.
73	Списание	Lor E, Takagi J. Visual compatibility of foscarnet with other injectable drugs. Am J Hosp Pharm 1990 ; 47: 157-159.
198	Списание	Gayed AA, Kheshary PR, Hinkle RL. Visual compatibility of diltiazem injection with various diluents and medications during simulated Y-site injection. Am J Health-Syst Pharm 1995 ; 52: 516-520.
275	Списание	Lewis JD, El-Gendy A. Cephalosporin-pentamidine isethionate incompatibilities. Am J Health-Syst Pharm 1996 ; 53: 1461-1462.
337	Списание	Bashaw ED, Amantea MA, Minor JR, Galleli JF. Visual compatibility of zidovudine with other drugs during simulated Y-site administration. Am J Hosp Pharm 1988 ; 45: 2532-2533.
424	Списание	De NC, Alam AS, Kapoor JN. Stability of pentamidine isethionate in 5% dextrose and 0.9% sodium chloride injections. Am J Hosp Pharm 1986 ; 43: 1486-1488.
496	Списание	Lor E, Sheybani T, Takagi J. Visual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administration. Am J Hosp Pharm 1991 ; 48: 744-746.
604	Лаборатория	Stabilité des médicaments dans l'Intermate® SV50, 100, 200 Baxter 1998
1135	Списание	Baltz JK, Kennedy P, Minor JR, Gallelli J. Visual compatibility of foscarnet with other injectable drugs during simulated Y-site administration. Am J Hosp Pharm 1990 ; 47: 2075-2077.
1235	Списание	Leigh PH, Buddle GC. Pentamidine infusion stability. Br J Pharm Pract 1988 ; 10: 22-23.
1625	Списание	Trissel LA, Saenz C, Williams YW, Ingram D. Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2001 ; 5: 314-321.
1925	Списание	Trissel LA , Williams KY, Gilbert DL. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions. J Am Pharm Assoc 2000 ; 40: 515-519.
3543	Лаборатория	Ceftazidime – Summary of Product Characteristics Wockhardt 2013
3559	Лаборатория	Pentamidine diiséthionate (Pentacarinat®) - Résumé des caractéristiques du produit Sanofi Aventis France 2013
3560	Лаборатория	Linezolid (Zyvox®) - Summary of Product Characteristics Pharmacia 2013
3662	Лаборатория	Foscavir (Foscarnet®) - Summary of Product Characteristics Clinigen 2014

Mentions Légales